These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 19005462)

  • 1. Direct in vivo xenograft tumor model for predicting chemotherapeutic drug response in cancer patients.
    Rubio-Viqueira B; Hidalgo M
    Clin Pharmacol Ther; 2009 Feb; 85(2):217-21. PubMed ID: 19005462
    [No Abstract]   [Full Text] [Related]  

  • 2. The search for optimal response prediction in cancer leads to a personalized approach.
    Van Cutsem E; Ciardiello F
    Target Oncol; 2010 Mar; 5(1):3-4. PubMed ID: 20349283
    [No Abstract]   [Full Text] [Related]  

  • 3. The hollow fibre model in cancer drug screening: the NCI experience.
    Decker S; Hollingshead M; Bonomi CA; Carter JP; Sausville EA
    Eur J Cancer; 2004 Apr; 40(6):821-6. PubMed ID: 15120037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The challenge of selecting the 'right' in vivo oncology pharmacology model.
    Firestone B
    Curr Opin Pharmacol; 2010 Aug; 10(4):391-6. PubMed ID: 20634135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CUDC-305, a novel synthetic HSP90 inhibitor with unique pharmacologic properties for cancer therapy.
    Bao R; Lai CJ; Qu H; Wang D; Yin L; Zifcak B; Atoyan R; Wang J; Samson M; Forrester J; DellaRocca S; Xu GX; Tao X; Zhai HX; Cai X; Qian C
    Clin Cancer Res; 2009 Jun; 15(12):4046-57. PubMed ID: 19509149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leukaemia xenotransplantation in zebrafish--chemotherapy response assay in vivo.
    Corkery DP; Dellaire G; Berman JN
    Br J Haematol; 2011 Jun; 153(6):786-9. PubMed ID: 21517816
    [No Abstract]   [Full Text] [Related]  

  • 7. Activated CD4+ T cells dramatically enhance chemotherapeutic tumor responses in vitro and in vivo.
    Radfar S; Wang Y; Khong HT
    J Immunol; 2009 Nov; 183(10):6800-7. PubMed ID: 19846868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bee toxin takes the sting out of cancer.
    Harrington M
    Lab Anim (NY); 2009 Oct; 38(10):312. PubMed ID: 19773766
    [No Abstract]   [Full Text] [Related]  

  • 9. Q&A: John Dick on stem cells and cancer.
    Dick J
    Cancer Discov; 2013 Feb; 3(2):131. PubMed ID: 23400460
    [No Abstract]   [Full Text] [Related]  

  • 10. From human to mouse and back: 'tumorgraft' models surge in popularity.
    Garber K
    J Natl Cancer Inst; 2009 Jan; 101(1):6-8. PubMed ID: 19116380
    [No Abstract]   [Full Text] [Related]  

  • 11. Catch of the day: zebrafish as a human cancer model.
    Stoletov K; Klemke R
    Oncogene; 2008 Jul; 27(33):4509-20. PubMed ID: 18372910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The metal-binding domain of IGFBP-3 selectively delivers therapeutic molecules into cancer cells.
    Huq A; Singh B; Meeker T; Mascarenhas D
    Anticancer Drugs; 2009 Jan; 20(1):21-31. PubMed ID: 19342998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patient-derived tumor xenograft models in drug development.
    Hidalgo M
    Clin Adv Hematol Oncol; 2017 Nov; 15(11):844-846. PubMed ID: 29200416
    [No Abstract]   [Full Text] [Related]  

  • 14. Moving ahead with personalized mouse models.
    Bender E
    Cancer Discov; 2013 Nov; 3(11):1214. PubMed ID: 24203942
    [No Abstract]   [Full Text] [Related]  

  • 15. Cancer: Xenograft encyclopaedia identifies drug combination opportunities.
    Cully M
    Nat Rev Drug Discov; 2015 Dec; 14(12):818. PubMed ID: 26585532
    [No Abstract]   [Full Text] [Related]  

  • 16. Advances and challenges in the use of biomarkers in clinical trials.
    Chabner B
    Clin Adv Hematol Oncol; 2008 Jan; 6(1):42-3. PubMed ID: 18322440
    [No Abstract]   [Full Text] [Related]  

  • 17. Potential use of cetrimonium bromide as an apoptosis-promoting anticancer agent for head and neck cancer.
    Ito E; Yip KW; Katz D; Fonseca SB; Hedley DW; Chow S; Xu GW; Wood TE; Bastianutto C; Schimmer AD; Kelley SO; Liu FF
    Mol Pharmacol; 2009 Nov; 76(5):969-83. PubMed ID: 19654225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Berberine inhibits human tongue squamous carcinoma cancer tumor growth in a murine xenograft model.
    Ho YT; Yang JS; Lu CC; Chiang JH; Li TC; Lin JJ; Lai KC; Liao CL; Lin JG; Chung JG
    Phytomedicine; 2009 Sep; 16(9):887-90. PubMed ID: 19303753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gold (III) porphyrin complexes induce apoptosis and cell cycle arrest and inhibit tumor growth in colon cancer.
    Tu S; Wai-Yin Sun R; Lin MC; Tao Cui J; Zou B; Gu Q; Kung HF; Che CM; Wong BC
    Cancer; 2009 Oct; 115(19):4459-69. PubMed ID: 19572413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antitumor efficacy and molecular mechanism of TLK58747, a novel DNA-alkylating prodrug.
    Xu H; Wang Z; Donaldson JC; Yao H; Zhou S; Kelson AB; Ma W; Weber KT; Laborde E; Cheng M; Sambucetti L; Keck JG
    Anticancer Res; 2009 Oct; 29(10):3845-55. PubMed ID: 19846918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.